ABSTRACT Background: Plasma concentrations of several trace elements and vitamins decrease because of the systemic inflammatory response. Thus, low values do not necessarily indicate deficiency. Objective: The magnitude of this effect on plasma micronutrient concentrations was investigated to provide guidance on the interpretation of routine clinical results. Design: Between 2001 and 2011, the results (2217 blood samples from 1303 patients) of routine micronutrient screens (plasma zinc, copper, selenium, and vitamins A, B-6, C, and E) and all vitamin D results (4327 blood samples from 3677 patients) were extracted from the laboratory database. C-reactive protein concentrations were measured as a marker of the severity of inflammation and categorized into 6 groups; for each group, plasma micronutrient concentrations and percentage changes were calculated. Results: Except for copper and vitamin E, all plasma micronutrient concentrations decreased with increasing severities of the acute inflammatory response. For selenium and vitamins B-6 and C, this occurred with only slightly increased C-reactive protein concentrations of 5 to 10 mg/L. For each micronutrient, the change in plasma concentrations varied markedly from patient to patient. The magnitude of the effect was greatest for selenium and vitamins A, B-6, C, and D, for which the median plasma concentrations decreased by .40%. Conclusions: The clinical interpretation of plasma micronutrients can be made only with knowledge of the degree of inflammatory response. A reliable clinical interpretation can be made only if the C-reactive protein is ,20 mg/L (plasma zinc), ,10 mg/L (plasma selenium and vitamins A and D), or ,5 mg/L (vitamins B-6 and C).
INTRODUCTION
The basis of routine laboratory assessment of micronutrient status is currently focused on their direct measurement in plasma. However, the SIR 4 associated with acute and chronic injury and infection alters concentrations of a wide range of trace elements and vitamins in plasma independently of tissue stores (1) (2) (3) (4) . For example, during elective surgery, the evolution of SIR, as determined on the basis of elevated CRP concentrations, is associated with transient decreases in plasma concentrations of zinc, selenium (5, 6) , iron (7, 8) , vitamin A, vitamin E, carotenoids (9, 10) , riboflavin, vitamin B-6 (11) vitamin C (12, 13) , and vitamin D (14) .
Although the effect of SIR on plasma micronutrient concentrations is known, it has not translated into changes in clinical practice with regard to the routine interpretation and reporting of plasma micronutrient concentrations. For example, in an audit that we conducted in the United Kingdom, 18% of Intensive Care Units do not consider the effects of SIR on plasma trace element concentrations, and 10% of them supplement patients with zinc on the basis of plasma measurements alone. Furthermore, in a Scottish audit of Nutrition Management Teams, 13% were unaware of the difficulty of interpreting plasma micronutrient concentrations in the presence of a SIR. More importantly, recent National Institute of Clinical Excellence guidelines highlight the importance of monitoring micronutrient concentrations in patients receiving total parenteral nutrition (15) ; however, no guidelines have been developed on how plasma micronutrient concentrations should be interpreted in the presence of a SIR.
The aim of the current study was to examine the effect of the magnitude of SIR on plasma micronutrient concentrations in a large cohort of patients whose blood samples were referred to the Scottish Trace Element and Micronutrient Reference Laboratory for assessment of their micronutrient status. This investigation was conducted with the intent of developing local guidelines to aid in the interpretation of results.
2001 and March 2011 for routine micronutrient analysis. The individual analytes involved in a micronutrient screen were zinc, copper, selenium, the fat-soluble vitamins A and E, and the watersoluble vitamins B-6 and C. In our laboratory, manganese, thiamine, and riboflavin are measured in erythrocytes and were therefore not included in the study. Vitamin C was only measured if the plasma sample was prepared within 4 h and stabilized by diluting it with an equal volume of 6% metaphosphoric acid. The median time period between sampling of individual patients was 3 mo (range: 0.5-11 mo; interquartile range: 1-6 mo). During the same period of time 5154 blood samples from 3676 patients (64% females, 36% males; median age: 59 y; range: 20-99 y; interquartile range: 47-71 y) were received from Hospitals throughout Scotland for vitamin D analysis.
Plasma vitamin A (retinol) and vitamin E (a-tocopherol) were measured by HPLC (16) . The intraassay CV was ,9% for both analytes over the sample concentration range. Plasma vitamin B-6 (pyridoxyl phosphate) was measured by HPLC by using precolumn semicarbazide derivatization and fluorescent detection (17) . The intraassay imprecision was 4.9% at 59 nmol/L and 6.3% at 16 nmol/L.
Plasma vitamin C (ascorbic acid) status was assessed by using a method based on that of Margolis and Davis (18) . Briefly, plasma was stabilized and deproteinized with 60 g metaphosphoric acid/L (stored at 4-8°C and prepared fresh every 2 weeks) and centrifuged and an aliquot of supernatant fluid was injected on a C 18 reversed-phase analytic column (Nucleosil). After separation, ascorbic acid was determined by coulometric electrochemical detection (ESA 5100A). The within-batch imprecision was 3.7% at a concentration of 38 lmol/L.
Plasma vitamin D (25-hydroxyvitamin D) status was measured by using an enzyme immunoassay kit (Immunodiagnostic Systems Ltd) until 2009, when tandem mass spectrometry was used (Waters Acuity; UPLC and TQD). Intraassay imprecision was ,10%.
Plasma zinc and copper were measured by inductively coupled plasma atomic emission spectrometry (Vista, Varian) and selenium by atomic absorption spectrometry (Perkin-Elmer) until 2006, and then all 3 were measured by inductively coupled plasma mass spectrometry (Agilent Technologies). Intraassay imprecision was ,4% for each of these analytes.
CRP was measured by routine laboratory procedures with an automated analyzer (Architect; Abbott Diagnostics). The limit of detection varied from 0. The laboratory participated in external quality assurance/ proficiency testing programs (trace element quality assurance scheme; UK NEQAS for vitamin assays; UK NEQAS for CRP; Proficiency Testing Program, Wadsworth Center; Instand EQA Scheme for vitamins) throughout the time period of the study. Performance was acceptable throughout, which indicated that methodologic changes did not result in any bias.
Two sample populations were analyzed statistically: all 2217 samples received from the 1303 patients and the first samples received from each of the 1303 patients. For vitamin D, all 5154 samples from 3676 patients and the first sample from each of these patients were analyzed. The concentrations of individual analytes were separated according to 6 categories of CRP concentrations: detection limit to 5, 6-10, 11-20, 21-40, 41-80, and .80 mg/L. For each category of CRP concentration, data are presented as medians and 2.5th, 25th, 75th, and 97.5th percentiles. The concentration of each analyte was compared with those whose CRP concentrations were 5 mg/L by using the Mann-Whitney U test. For each category of CRP concentration, the percentage of individual micronutrient concentrations below the lower limit of our laboratory reference range was calculated. Correlations of plasma micronutrient concentrations compared with CRP, logged to correct for skewness, were expressed as Spearman correlation coefficients. The numerical proportions of low micronutrient concentrations for the categories were compared with that of 5 mg/L y using a contingency table analysis with the chi-square test for trend as appropriate. A P value ,0.01 was considered to be significant because of the number of statistical comparisons. The analysis was performed with the use of SPSS software (version 15; SPSS Inc).
RESULTS
The effect of SIR, as determined on the basis of CRP concentrations, on median percentage changes in concentrations of zinc, selenium, copper, and vitamins A, E, D, B-6, and C are shown in Figure 1 . Full data, expressed as medians, interquartile ranges, 2.5th and 97.5th percentiles, and statistical P values are shown in Tables 1-8 . With the exception of vitamin E and copper, all micronutrients showed similar significant trends of decreasing plasma concentrations as CRP concentrations increased. With selenium and vitamins B-6 and C, this decrease was significant when CRP concentrations were only slightly elevated (between 5 and 10 mg/L). For vitamins A and D, the decrease was significant when CRP concentrations were modestly elevated (between 10 and 20 mg/L), and zinc concentrations were significantly lowered with CRP concentrations .20 mg/L. CRP concentrations of .80 mg/L were associated with the largest decreases in plasma micronutrient concentrations. The median percentage decreases in plasma micronutrients ( Figure  1) were, in order of magnitude, as follows: vitamin C, 78%; vitamin B-6, 69%; vitamin A, 50%; selenium, 48%; vitamin D, 41%; and zinc, 20%. However, the effect was highly variable; for example, the interquartile ranges were as follows: vitamin C, 52-91%; vitamin B-6, 50-69%; vitamin A, 25-70%; selenium, 25-65%; vitamin D, 6-56%; and zinc, 4-38%.
The correlation coefficients of plasma micronutrients compared with log CRP concentrations were as follows: vitamin C (r = 20.4, P , 0.01), vitamin B-6 (r = 20.39, P , 0.01), vitamin A (r = 20.16, P , 0.01), selenium (r = 20.40, P , 0.01), vitamin D (r = 20.16, P , 0.01), and zinc (r = 20.17, P , 0.01). For copper, there was an initial increase in plasma concentrations with increasing severity of SIR. However, this effect diminished with CRP concentrations .40 mg/L ( Figure  1C , Table 3 ). The correlation coefficient of plasma copper compared with log CRP concentration was r = 0.25 (P , 0.01).
For vitamin E, a slight initial increase in concentration with increasing CRP concentration was observed, which was significant only with CRP concentrations of 5 to 10 mg/L; at high CRP concentrations (.80 mg/L), vitamin E concentrations decreased. The correlation coefficient for the comparison of plasma vitamin E with log CRP concentration was not statistically significant.
The percentages of results below the lower end of the reference range at each CRP concentration category are shown in Table 9 . For all micronutrients, there were significantly more results below the lower reference range limit as CRP concentrations increased. The effect was relatively modest for copper and vitamin E, but was more profound for the other micronutrients; with CRP concentrations .80 mg/L, the percentage of results below the lower reference limit increased by 19% for vitamin D, 27% for selenium, 41% for vitamin A, 47% for vitamin C, and 53% for vitamin B-6.
DISCUSSION
By categorizing plasma micronutrient results into 6 groups according to increasing CRP concentrations, the current study showed the considerable effect that SIR has on their concentrations. The effect of SIR in lowering plasma selenium and vitamins A, B-6, C, and D was apparent with only slightly elevated CRP concentrations. In addition, the magnitude of the effect on plasma concentrations of selenium, zinc, and vitamins A, B-6, C, and D was often substantial, particularly with high CRP concentrations. This makes the interpretation of these micronutrients increasingly difficult as CRP concentrations rise. The magnitude of the effect was also highly variable, invalidating the possibility of refining interpretation (or identification of deficiency) based on CRP concentrations.
The effect of SIR on decreasing concentrations of several micronutrients and the possibility that this may occur independently of actual nutritional status were previously reported (1-4). Therefore, there is a risk of misinterpreting the results as indicating deficiency. Despite the documentation of this information in the literature, a general lack of awareness remains in routine clinical medicine. For example, in our experience, many requests are received from patients in Intensive Care Units and in surgical wards and from other patients with a marked SIR. For this reason, our routine clinical practice is to use the CRP concentration as a marker of systemic inflammation in all routine micronutrient requests, so that a more informed interpretation can be made.
It is likely that the effects of SIR on plasma micronutrient concentrations are, at least in part, mediated by proinflammatory cytokines that suppress hepatic production of many carrier proteins, increase capillary permeability, and promote sequestration of some micronutrients into the liver and other organs (19) . For example, with increasing vascular permeability, plasma albumin and retinol binding protein leak into the extravascular space. With reference to plasma albumin, this will result in decreases in plasma zinc and vitamin B-6. Although it is generally considered that plasma vitamin C is not protein bound, there is evidence of its binding to serum albumin and that this may play a significant transport role (20, 21) . With reference to retinol binding protein, this will result in a decrease in vitamin A. Also, much of the circulating selenium is in the form of selenoprotein P (22)-a low-molecular-weight protein (23) that is also readily redistributed from the plasma. In contrast, the concentration of ceruloplasmin increases as a result of increased liver synthesis, as do concentrations of its constituent copper. Another mechanism for the decrease in plasma zinc and vitamin B-6 is their sequestration into liver and other tissues as SIR develops (24, 25) . It was also of interest that the effect of SIR on plasma vitamin E concentrations was relatively small. This may be explained by the large size of the lipoprotein in which vitamin E is mainly incorporated, which limits its transfer across capillaries into the extravascular space. Some of the reduction in plasma micronutrient concentrations may also be due to increased utility, metabolism, or excretion, which suggests a degree of potential deficiency. However, it is impossible to quantify the relative contribution of these mechanisms on the basis of plasma micronutrient concentrations.
In the current study, it was clear that as the severity of SIR increased, the proportion of results below the lower reference limit increased. Also, the correlation coefficients of CRP concentrations compared with the individual micronutrients were all relatively weak, which indicates that the association is highly variable from patient to patient. This is perhaps not surprising because the data were accumulated from a wide cross-section of patients with differing types and severities of medical conditions as well as varied degrees of micronutrient deficiencies. Furthermore, it would be expected that increased utilization and turnover of micronutrients occurs in conditions associated with an SIR. Taken together, this emphasizes the difficulty of the interpretation of plasma micronutrient concentrations in the presence of moderate or severe SIR. Failure to take account of the effects of SIR may result in decreased plasma concentrations of micronutrients being misinterpreted as indicating deficiency and thus may result in inappropriate supplementation. In the case of zinc, this may cause severe neurologic sequelae resulting from iatrogenic zinc-induced copper deficiency (26) .
These results, however, do raise the issue of whether there are micronutrient concentrations below which deficiency is present irrespective of the SIR; such patients may truly be deficient but go untreated because of elevated CRP concentrations. For example, the data presented in Figure 1 suggest that patients with a plasma zinc concentration ,6 lmol/L may be truly deficient. However, the validity of such an approach cannot be addressed by the current study because other measures of zinc status are required, eg, intracellular concentrations or functional tests.
An alternative solution to the confounding effect of SIR is to measure the micronutrient in an alternative matrix, such as in red blood cells; to use CRP, micronutrient carrier proteins, or their surrogates to correct results (27) (28) (29) ; or to measure micronutrients functionally. We have successfully used the former approach, measuring riboflavin, vitamin B-6 in red blood cells, and thiamine in whole blood. We recently found that selenium in red blood cells correlates with plasma selenium across a wide range of concentrations and thus can be reliably used as an alternative to plasma selenium in assessing status. It is unlikely, however, that red blood cell zinc will be similarly useful (30) . However, the use of functional analyses such as the use of glutathione peroxidase as a marker of selenium status presents problems typically associated with the measurement of enzyme activity, such as difficulties in standardizing assay conditions that result in poor analytic precision and interlaboratory comparability (31) . In addition, no external quality assurance scheme is available; therefore, the analytic performance is difficult to validate. Functional analyses may also have other disadvantages, such as the effect of disease in depleting the apoenzyme, abnormal binding of variants, and the effects of other cofactor deficiencies (32) such as magnesium deficiency, which causes the reduced cellular activity of thiamine.
The results of the current study, although clear because of their cross-sectional nature, cannot prove a causal effect of the systemic inflammatory response on micronutrient concentrations. There may be an underlying physiologic process that alters both the micronutrient concentrations and the systemic inflammatory response, so that the observed relations could at times be indirect. One plausible example might be that sick persons with inflammation may also have poor appetites and hence reduced nutrient intakes and altered plasma micronutrient concentrations. In such a case, the altered concentrations would, at least in part, be a genuine reflection of their reduced overall body nutrient status and only indirectly linked to the increased inflammatory response. However, it is of interest that when plasma and intracellular measurements of such micronutrients are carried out, although there is a considerable effect of the systemic inflammatory response on lowering plasma concentrations, there is little effect on intracellular concentrations (5, 27, 33) . Therefore, we conclude that the assumption of causation is reasonable but not yet definitively proven. The inclusion of more than one sample for each patient means that the observations noted were not strictly independent. However, because the patients were undergoing active management, their metabolic and nutritional status was considered to be in a dynamic state; therefore, repeat observations for an individual were not considered to represent duplication. This was essentially confirmed when we also analyzed the data based only on the first sample received from each patient and found entirely consistent observations throughout (see supplemental tables under "Supplemental data" in the online issue). The inclusion of all data in the analysis served only to strengthen the statistical findings.
In summary, the results of the current study indicate that a SIR has a significant effect on the plasma concentrations of a variety of micronutrients within the context of a routine clinical service. We recommend that clinical interpretation of plasma micronutrients only be made when the CRP concentration is known (an indicator of the inflammation) or the presence of SIR is excluded. Our data suggest that, in the presence of moderate or severe SIR (as indicated by a CRP concentration .20 mg/L), plasma concentrations of selenium, zinc, and vitamins A, B-6, C, and D are clinically uninterpretable. With a less severe SIR and lower concentrations of CRP, it is appropriate to report plasma micronutrient results as follows: zinc is interpretable when CRP concentrations are ,20 mg/L, plasma selenium and vitamins A and D are interpretable when CRP concentrations are ,10 mg/L, and vitamins C and B-6 can only be interpreted when CRP concentrations are ,5 mg/L.
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